Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe hemophilia A

Información del proyecto

HemAcure

Identificador del acuerdo de subvención: 667421

DOI 10.3030/667421

Proyecto cerrado

Fecha de la firma de la CE 9 Diciembre 2015

Fecha de inicio 1 Noviembre 2015

Fecha de finalización 31 Octubre 2018

Financiado con arreglo a

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Coste total € 5 564 395,00

Aportación de la UE € 5 564 395,00

Coordinado por

UNIVERSITAETSKLINIKUM WUERZBURG - KLINIKUM DER BAYERISCHEN JULIUS-MAXIMILIANS-UNIVERSITAT
Germany

Resultado final

Documents, reports (2)

Exploitation activity (as above)
Individualized press release for every partner

Other (1)

Final dissemination activity on project results

Websites, patent fillings, videos etc. (1)

Launch of website, Twitter, Facebook, LinkedIn etc.

Publicaciones

Other (1)

Combined ATMPs Containing Genetically Modified Cells

Autores: Patrick Bittorf, Martin Zierau, Ralf Sanzenbacher, Heike Walles, Joris Braspenning
Publicado en: Pharmazeutische Medizin, 2017, Página(s) 168-174
Editor: DeGePe GmbH

Thesis and dissertations (2)

"""Use of BOECs for therapeutic applications"""

Autores: Miguel Rodrigues
Publicado en: 2018
Editor: University of Wuerzburg

Genetically modified cells for treatment of heamophilia A

Autores: Patrick Bittorf
Publicado en: 2019
Editor: University Würuburg

Conference proceedings (4)

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A

Autores: Chiara Borsotti, Simone Merlin, Cristina Olgasi, Thorsten Bergmann, Delfina M. Mazzuca, Alexandra Stolzing, Martin Zierau, Philip M. Toleikis, Joris Braspenning and Antonia Follenzi
Publicado en: Blood Transfusion, Edición Vol.15, Supplement No. 3, September 2017, 2017, Página(s) s483, ISSN 1723-2007
Editor: Edizioni SIMTI

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A

Autores: C Olgasi, S Merlin, C Borsotti, T Bergmann, D M Mazzucca, A Stolzing, M Zierau, P M Toleikis, J Braspenning, A Follenzi  
Publicado en: ESGCT abstract book 2018, Edición 16th-19th October 2018, 2018
Editor: ESGCT

Application of combined gene and cell therapy within an implantable therapeutic device for the treatment of severe haemophilia A (poster presentation at ESGCT congress, Berlin, 2017)

Autores: Cristina Olgasi, Simone Merlin, Thorsten Bergmann, Chiara Borsotti, Delfina M. Mazzuca, Alexandra Stolzing, Martin Zierau, Philip M. Toleikis, Joris Braspenning and Antonia Follenzi
Publicado en: Human Gene Therapy, Edición Vol.28, No. 12, 1st December 2017, 2017, Página(s) pp A92, ISSN 1043-0342
Editor: Mary Ann Liebert

Advancing Tissue and Regenerative Engineering in UK Medicine (ATREUM) abstracts booklet

Autores: Harrison, Richard P., Adams, Christopher F.
Publicado en: 2017, ISBN 978-0-9955941-0-4
Editor: University Loughborough